Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 4Completed 3Terminated 2Unknown 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Classical hematology 1

Conditions

Pancreatic Neoplasms 3Peutz-Jeghers Syndrome 1Fanconi Anemia, Complementation Group D1 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Secretin × Clear all
NCT03404661 2023-06-06

Optical and Biochemical Biomarkers in Early Pancreatic Cancer

Mayo Clinic

Completed
346 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00438906 2021-06-18

CAPS 3

Johns Hopkins University

Completed
200 enrolled
Classical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Pancreatic Neoplasms, Peutz-Jeghers Syndrome

NCT01094561 2016-09-09

Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients

Columbia University

Phase NA Completed
23 enrolled 5 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡